News (518)

Roche: AGM approves dividend increase CF
Roche Annual General Meeting 2024 GL
[Ad hoc announcement pursuant to Art. 53 LR] Roche exceeds guidance and achieves sales growth of 1% (CER) for 2023 despite sharp COVID-19 sales decline GL
Roche Annual General Meeting 2023 GL
Roche Holding AG Approves Board and Board Committee Changes CI
Switzerland Roche AQ
Transcript : Roche Holding AG, 2022 Earnings Call, Feb 02, 2023
Roche : Full-Year 2022 Presentation with appendix PU
Roche : Full-Year 2022 Presentation PU
Roche : Full-Year 2022 Investor Update PU
[Ad hoc announcement pursuant to Art. 53 LR] Changes in Roche’s Corporate Executive Committee GL
[Ad hoc announcement pursuant to Art. 53 LR] Changes in Roche’s Corporate Executive Committee GL
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results for 2022 despite decline in demand for COVID-19 products GL
Reminder: Invitation to Roche’s Full Year Results 2022 Presentation PU
Invitation to Roche's Full Year Results 2022 Presentation AQ
Roche names new CEO with Schwan set to become chairman RE
[Ad hoc announcement pursuant to Art. 53 LR] Roche: Changes in the Board of Directors and the Corporate Executive Committee GL
Roche's Alzheimer's drug fails to meet goal in long awaited trial RE
Roche's Alzheimer's drug fails to meet goal in long awaited trial RE
Transcript : Roche Holding AG, Q3 2022 Sales/ Trading Statement Call, Oct 18, 2022
Roche : Nine-month 2022 Sales presentation PU
Roche : Nine-month 2022 Sales presentation with appendix PU
[Ad hoc announcement pursuant to Art. 53 LR] Roche records solid results for the first nine months of 2022 GL
[Ad hoc announcement pursuant to Art. 53 LR] Roche: Change in the Corporate Executive Committee in January 2023 GL
Invitation to Roche's 3rd Quarter Sales 2022 Webinar AQ
Chugai Pharmaceutical Co., Ltd. - Anti-C5 Recycling Antibody Crovalimab Obtains Priority Review in China for the Treatment of Paroxysmal Nocturnal Hemoglobinuria AQ
Chugai Pharmaceutical : Anti-C5 Recycling Antibody Crovalimab Obtains Priority Review in China for the Treatment of Paroxysmal Nocturnal Hemoglobinuria PU
ROCHE HOLDING : Another quarterly beat but full-year guidance is maintained Alphavalue
Chugai Pharmaceutical Co., Ltd. - F. Hoffmann-La Roche Announces Half Year Results 2022 AQ
Transcript : Roche Holding AG, H1 2022 Earnings Call, Jul 21, 2022
Chugai Pharmaceutical : Partial Revision of the Basic Alliance Agreement with Roche PU
Roche Appoints Next CEO; Board to Propose Current CEO Take Chairman Role DJ
Roche diagnostics head to take helm of Swiss pharma giant RE
Roche : Half-Year 2022 Presentation PU
Roche diagnostics head to become group CEO RE
Chugai Pharmaceutical : F. Hoffmann-La Roche Announces Half Year Results 2022 PU
[Ad hoc announcement pursuant to Art. 53 LR] Roche: Change in the Board of Directors and Corporate Executive Committee in Spring 2023 GL
[Ad hoc announcement pursuant to Art. 53 LR] Roche: Change in the Board of Directors and Corporate Executive Committee in Spring 2023 GL
Roche Holding AG Announces Executive Changes CI
[Ad hoc announcement pursuant to Art. 53 LR] Roche achieves good results in the first six months of 2022 GL
[Ad hoc announcement pursuant to Art. 53 LR] Roche achieves good results in the first six months of 2022 GL
Transcript : Credit Suisse Group AG - Shareholder/Analyst Call
Credit Suisse : Earnings Release 1Q22 - Form 6-K PU
Chugai Pharmaceutical Co., Ltd. - F. Hoffmann-La Roche Announces First Quarter Sales 2022 AQ
Transcript : Roche Holding AG, Q1 2022 Sales/ Trading Statement Call, Apr 25, 2022
1234NextSee all

Companies (1)

S.C. SEVERNAV S.A. - $
Logo S.C. Severnav S.A.

Severnav SA is a Romania-based company primarily engaged in the construction and maintenance of ships and floating structures. The Company’s portfolio includes liquefied gas carriers, inland chemical tankers, cargo vessels, passenger ships, multipurpose ...


Insiders

Severin Schwan
Severin Schwan

Dr. Severin Schwan is a Vice President at International Federation of Pharmaceutical Manufacturers, a Vice Chairman at Credit Suisse Group AG, a Member of the Board of Directors at Credit Suisse AG, a Member at European Round Table of Industrialists, a Member at International Business Leaders Advisory Council, a Chairman at Roche Holdings, Inc., a Chief Executive Officer at Roche Group, a Chief Executive Officer & Executive Director at Roche Holding AG, a Chief Executive Officer & Director at F. Hoffmann-La Roche Ltd., a Chairman at Genentech, Inc., a Chairman at Roche Pharma Schweiz AG, a Chairman-Supervisory Board at Roche Diabetes Care GmbH, a Chairman-Supervisory Board at Roche Diagnostics Deutschland GmbH and a Chairman-Supervisory Board at Roche Pharma AG. He is on the Board of Directors at Credit Suisse Group AG, Credit Suisse AG, Roche Holding AG and F. Hoffmann-La Roche Ltd. Dr. Schwan was previously employed as a Chief Executive Officer by Roche Diagnostics Corp., a Head-Asia Pacific Region by Roche Diagnostics Asia Pacific Pte Ltd., a Head-Global Finance & Services by Roche Diagnostics AG, a Member-Executive Board by Roche Deutschland Holding GmbH, a Head-Finance & Administration by Roche (Brussels), and a Chairman-Member-Supervisory Board by Roche Diagnostics GmbH. He also served on the board at Credit Suisse (Schweiz) AG and Chugai Pharmaceutical Co., Ltd. He received his graduate degree from the University of Innsbruck and a doctorate degree from the University of Innsbruck.


Picture Severin Hacker
Severin Hacker

Dr. Severin Hacker is a Director & Chief Technology Officer at Duolingo, Inc. He is on the Board of Directors at Duolingo, Inc. He received his undergraduate degree from Swiss Federal Institute of Technology and a doctorate degree from Carnegie Mellon University.







Picture Ursula Schwan
Ursula Schwan

Ursula Schwan founded Schwan Moden GmbH in 1992.



Picture Axel Schwan
Axel Schwan

Axel Schwan is currently the Director at Tim Hortons USA, Inc. He is also the President-Tim Hortons Americas Region at Restaurant Brands International, Inc. and the President-Tim Hortons Americas at Restaurant Brands International LP.
Previously, he served as the Global Chief Marketing Officer & Executive VP at Burger King Worldwide, Inc. from 2014 to 2017.
He also held the position of President-Burger King APAC at Burger King Corp.
from 2014 to 2016.










Picture Elisabeth A. Schwan
Elisabeth A. Schwan

Ms. Elisabeth A.
Schwan
, CFA MBA, is a Director of Research at Radnor Capital Management LLC (RCM).
She is also a equity securities analyst where she produces investment ideas and information based on quantitative and fundamental research.
She has served in this capacity since the firm’s inception in 2012.
She has been in the investment business since 1982.
Before RCM, she held a similar position with the former Radnor Capital Management “1.0” and its successor companies, which included U.S.
Trust Company and Columbia Management Investment Advisers, spanning the period 1992-2012.
Prior to this, she was a securities analyst at American Capital Management & Research, where she developed value-oriented stock ideas and assisted the manager of a mutual fund.
She also held equity analyst positions at David L.
Babson and Liberty Mutual Insurance Company.
Before the investment business, she worked for Burlington Industries in various assignments in audit, market research, and controller’s staffs.
She is a member of the Chartered Financial Analyst Institute and CFA Society of Philadelphia.
She received a B.A.
in Economics from Bryn Mawr College and an M.B.A.
from the University of Virginia.






Picture Scott Schwan
Scott Schwan

Scott Schwan has founded a company called Shujinko, Inc. in 2018, where he currently holds the title of Chief Executive Officer.




Picture Brandon Xavier Schwan
Brandon Xavier Schwan

Mr. Brandon X.
Schwan is a Vice President & Financial Advisor at Fragasso Financial Advisors, Inc. He received his Bachelor’s degree in Business Management from Purdue University.






Picture John H. Schwan
John H. Schwan

John H.
Schwan
is currently the Director at Leave No Veteran Behind, Pritzker Military Museum & Library, and Armed Forces Council of Chicago.
He was previously the Chairman at Yunhong Green CTI Ltd.
from 2017 to 2020, Principal at Rapak LLC from 1990 to 2006, and President & Owner at Packaging Systems, Inc. from 1980 to 1990.
He received his undergraduate degree from North Park University.



Picture Cilja Schwan
Cilja Schwan

Cilja Schwan worked as a Manager-Treasury at MPC Energy Solutions NV from 2021 to 2023.








Picture Marissa Schwan
Marissa Schwan

Marissa Schwan worked as a Senior Business Partner-Human Resources at The Standard Bank of South Africa Ltd.
and as Head-Vehicle Finance Division at ABSA Bank Ltd.
She also worked as Head-Human Resources at Bryte Insurance Co. Ltd.
from 2011 to 2016.




Picture J. Schwan
J. Schwan

J.
Schwan
is the founder of The Second Mountain LLC (founded in 2023) and Solstice Consulting LLC (founded in 2001).
Mr. Schwan is currently a Director at Ann & Robert H.
Lurie Family Foundation, ST Ives Burnley Ltd., Amaze Europe Ltd., Incite Marketing Planning Ltd., St. Ives Marketing Services Ltd., Branded3 Search Ltd., and Kin & Carta Group Ltd.
Mr. Schwan previously held the position of Chief Executive Officer at Solstice Consulting LLC from 2013 to 2018.
Mr. Schwan also has former experience as Chief Executive Officer & Executive Director at Kin + Carta Plc from 2018 to 2022.
Additionally, Mr. Schwan has held positions as a Director at Occam DM Ltd., The Health Hive Group Ltd., and Accenture Ltd.
Mr. Schwan obtained an undergraduate degree from the University of Illinois.


Picture Stephan Schwan
Stephan Schwan

Stephan Schwan worked as a Co-Managing Director at "Projektservice Schwan GmbH".


Picture Holger Schwan
Holger Schwan

Holger Schwan is the Managing Director & Managing Partner of "Projektservice Schwan GmbH".


Picture Elke Schwan
Elke Schwan

Elke Schwan currently works at MediClin AG, as Member-Supervisory Board from 2019.




Picture Schwan Badirou-Gafari
Schwan Badirou-Gafari

Schwan Badirou-Gafari is currently the Deputy Director-Investments at Agence des Participations de l’Etat, Director at Sfil SA, Director at Société D Economie Mixte Du Marche De Rungis, and Director at Société Pour Le Logement Intermediaire.
Previously, he held positions as Director at IN Groupe and Director at La Française des Jeux SA.




Picture Philip Schwan
Philip Schwan

Philip Schwan was the Chief Executive Officer of Cluster File Systems, Inc. He later worked at DUG Technology Ltd.
as the Director and Chief Technology Officer until 2020.






Picture Michael Schwan
Michael Schwan

Michael Schwan is currently a Member-Supervisory Board at VDE Verband der Elektrotechnik Elektronik Informationstechnik.
Previously, he worked as a Co-Managing Director at Schwan GmbH.




Picture Werner Severin
Werner Severin

Werner Severin worked as the Head of Operations and Management at Landesbank Saar from 2001 to 2017.
He also served as a member of the Supervisory Board at Deutsche Factoring Bank GmbH & Co. KG.






Picture Wes Severin
Wes Severin

Mr. Wes Severin is Vice President-Key Accounts & Retirement Sales at Symetra Life Insurance Co. Prior to joining Symetra in March 2011, he served with Great-West Life & Annuity Insurance Co. Mr. Severin received his undergraduate degree from Colorado State University.


Picture Severin Pelletier
Severin Pelletier

Severin Pelletier currently works as the President at Schneider Toshiba Inverter Europe SAS.





Picture Katharina Severin
Katharina Severin

Katharina Severin joined the Life Science Team as an Investment Analyst in September of 2021.
She was born and raised in the Ruhr area and spent time in the US and Asia during her education.
Among these stays was a one-year research stay in the lab of Tom Rapoport at Harvard Medical School in Boston.
Katharina obtained her PhD in Medical Biology and received numerous scholarships and awards, among them stipends from the German National Academic Foundation and the Christiane Nüsslein-Volhard Foundation.
Through networking opportunities from these foundations and as an attendee of the Lindau Nobel Laureate Meeting, Katharina discovered and cultivated her passion for interdisciplinary scientific exchange.
Her research findings mark a starting point for a novel therapeutic approach in the treatment of cancer.
Katharina is fascinated by entrepreneurial questions and is passionate about bringing scientific results and genious business ideas to profitable ventures.


Picture Peter Severin
Peter Severin

Peter Severin currently works as a Director & Vice President for the International Corrections & Prisons Association.









Picture Chadé Severin
Chadé Severin

Chadé Severin is currently a partner at Skadden, Arps, Slate, Meagher & Flom LLP.




Picture Severin Schmidt
Severin Schmidt

Severin Schmidt is currently working as a Principal at Stellex Capital Management UK LLP.
Previously, he worked as an Associate at Providence Equity LLP.
He holds an MBA from the University of Mannheim.








Picture Magnus Severin
Magnus Severin

Magnus Severin currently works at PlantVision AB, as Chief Sales & Marketing Officer from 1999.











Picture Severin Kollros
Severin Kollros

Severin Kollros currently works as the Head of Marketing & Communications at Auto AG Holding.

No results for this search